Position in LNSR
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$850
+$249 QoQ
Shares Held
149
+47.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 10 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LNSR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Farther Finance Advisors, LLC holds $24,008,566 across 88 Medical Devices names. LNSR ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
73,946 | $6,709,860 | |
| 2 | SYK |
Stryker Corp
|
17,426 | $5,486,401 | |
| 3 | MDT |
Medtronic plc
|
65,993 | $5,162,632 | |
| 4 | BSX |
Boston Scientific Corp
|
28,699 | $1,224,873 | |
| 5 | EW |
Edwards Lifesciences Corp
|
12,482 | $1,129,121 | |
| 6 | DXCM |
Dexcom Inc
|
9,967 | $671,277 | |
| 7 | STE |
STERIS plc
|
2,980 | $627,498 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
8,545 | $546,965 |
All Filings in LNSR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $850 | 149 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $601 | 101 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,174 | 101 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,247 | 101 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,330 | 101 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,426 | 101 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||